Correction to: Scientific Reports 10.1038/s41598-021-81726-2, published online 26 January 2021
The original version of this Article contained an error in Figure 7, where 'P-EGFR 0 mg/kg' in panel B was a duplication of 'AREG 1 mg/kg' in panel A.
The original Figure 7 and accompanying legend appear below.
Figure 7.
SAMiRNA-AREG inhibited EGFR phosphorylation by downregulating AREG in UUO- or AD-induced renal fibrosis. (a,b) Representative images of AREG expression and EGFR phosphorylation revealed overexpression in the UUO- or AD-induced models of renal fibrosis, which was attenuated by SAMiRNA-AREG administration (1 mg/kg or 5 mg/kg). The AREG- and p-EGFR-positive areas were quantified. Scale bar, 100 μm. ***p < 0.001 compared to UUO or AD mice by ANOVA with the Newman-Keuls post-hoc test.
The original Article has been corrected.
Contributor Information
Han‑Oh Park, Email: hpark@bioneer.com.
Eun Young Lee, Email: eylee@schmc.ac.kr.

